US Critical Metals Corp
USCM
Three Valley Copper Corp
TVC.H
Windfall Geotek Inc
WIN
Revive Therapeutics Ltd
RVV
Global Hemp Group Inc
GHG
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -43.27%198M | -6.87%244M | 64.41%97M | 156.75%1.12B | -21.53%452M | 496.59%349M | 226.57%262M | -62.18%59M | -78.48%437M | 41.18%576M |
Operating revenue | -43.27%198M | -6.87%244M | 64.41%97M | 156.75%1.12B | -21.53%452M | 496.59%349M | 226.57%262M | -62.18%59M | -78.48%437M | 41.18%576M |
Cost of revenue | -20.34%47M | -6.78%55M | -15.07%62M | -6.20%257M | 0.00%66M | -16.90%59M | -6.35%59M | -1.35%73M | -5.52%274M | -10.81%66M |
Gross profit | -47.93%151M | -6.90%189M | 350.00%35M | 430.67%865M | -24.31%386M | 282.39%290M | 175.19%203M | -117.07%-14M | -90.64%163M | 52.69%510M |
Operating expense | -40.54%22M | -118.42%-7M | 7.69%28M | 266.22%123M | -92.86%5M | 68.18%37M | 144.19%38M | 132.50%26M | -122.22%-74M | -39.13%70M |
Selling and administrative expenses | -50.00%7M | -145.16%-14M | 433.33%10M | 134.88%60M | -73.53%18M | 227.27%14M | 125.41%31M | 97.20%-3M | -169.92%-172M | -42.86%68M |
-General and administrative expense | -50.00%7M | -145.16%-14M | 433.33%10M | 134.88%60M | -73.53%18M | 227.27%14M | 125.41%31M | 97.20%-3M | -169.92%-172M | -42.86%68M |
Research and development costs | ---- | ---- | ---- | 20.00%6M | ---- | ---- | ---- | ---- | 0.00%5M | ---- |
Depreciation amortization depletion | -37.50%5M | 0.00%7M | -46.15%7M | -46.97%35M | -74.07%7M | -33.33%8M | -46.15%7M | -7.14%13M | 11.86%66M | 92.86%27M |
-Depreciation and amortization | -37.50%5M | 0.00%7M | -46.15%7M | -46.97%35M | -74.07%7M | -33.33%8M | -46.15%7M | -7.14%13M | 11.86%66M | 92.86%27M |
Other operating expenses | -33.33%10M | ---- | -31.25%11M | -18.52%22M | 13.33%-26M | -28.57%15M | ---- | 23.08%16M | 17.39%27M | -30.43%-30M |
Operating profit | -49.01%129M | 18.79%196M | 117.50%7M | 213.08%742M | -13.41%381M | 239.78%253M | 189.67%165M | -124.69%-40M | -83.17%237M | 100.91%440M |
Net non-operating interest income (expenses) | 0.00%-2M | 0.00%-2M | ||||||||
Non-operating interest expense | ---- | ---- | ---- | 0.00%2M | ---- | ---- | ---- | ---- | 0.00%2M | ---- |
Other net income (expenses) | -166.67%-2M | 15.63%-27M | 101.58%3M | -20,700.00%-208M | -50.00%-6M | 200.00%3M | -32M | -9,600.00%-190M | 50.00%-1M | 0.00%-4M |
Special income (charges) | -250.00%-3M | 26.67%-11M | 101.57%3M | -3,433.33%-212M | -33.33%-8M | --2M | ---15M | ---191M | -20.00%-6M | ---6M |
-Less:Restructuring and mergern&acquisition | -40.00%3M | -26.67%11M | -115.00%-3M | 733.33%50M | 66.67%10M | --5M | --15M | --20M | 20.00%6M | --6M |
-Less:Impairment of capital assets | --0 | --0 | --0 | --162M | ---2M | ---7M | --0 | --171M | --0 | --0 |
Other non-operating income (expenses) | 0.00%1M | 5.88%-16M | ---- | -20.00%4M | 0.00%2M | 0.00%1M | ---17M | -50.00%1M | 66.67%5M | 100.00%2M |
Income before tax | -50.39%127M | 27.07%169M | 104.35%10M | 127.35%532M | -14.06%373M | 242.22%256M | 172.28%133M | -240.24%-230M | -83.33%234M | 103.76%434M |
Income tax | 0 | 0.00%1M | 0 | 400.00%3M | 0 | 0 | 1M | 2M | 0.00%-1M | 0.00%-1M |
Earnings from equity interest net of tax | ||||||||||
Net income | -50.39%127M | 27.27%168M | 104.31%10M | 125.11%529M | -14.25%373M | 242.22%256M | 171.74%132M | -241.46%-232M | -83.27%235M | 103.27%435M |
Net income continuous operations | -50.39%127M | 27.27%168M | 104.31%10M | 125.11%529M | -14.25%373M | 242.22%256M | 171.74%132M | -241.46%-232M | -83.27%235M | 103.27%435M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -50.39%127M | 27.27%168M | 104.31%10M | 125.11%529M | -14.25%373M | 242.22%256M | 171.74%132M | -241.46%-232M | -83.27%235M | 103.27%435M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | -50.39%127M | 27.27%168M | 104.31%10M | 125.11%529M | -14.25%373M | 242.22%256M | 171.74%132M | -241.46%-232M | -83.27%235M | 103.27%435M |
Diluted earnings per share | -48.15%1.68 | 34.97%2.2 | 104.53%0.13 | 140.43%6.66 | -7.45%4.72 | 252.83%3.24 | 175.81%1.63 | -251.05%-2.87 | -82.46%2.77 | 104.00%5.1 |
Basic earnings per share | -47.99%1.68 | 34.36%2.19 | 104.53%0.13 | 140.07%6.65 | -7.65%4.71 | 252.36%3.23 | 175.81%1.63 | -251.85%-2.87 | -82.42%2.77 | 104.82%5.1 |
Dividend per share | -1.86%0.0722 | -3.04%0.0732 | 0.92%0.0746 | -27.03%0.223 | 0 | 0.61%0.0736 | -2.77%0.0755 | -7.70%0.0739 | -23.01%0.3055 | -4.74%0.0747 |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.